$AIM was halted just before 3pm ET. Pending news, T1 halt. A few minutes later, they announced an offering.
Why would they request a T1 halt just to announce an offering 😂
English
TwongStocks
930 posts
TwongStocks
@TwongStocks
Biotech trader/investor. Dumpster diving clinical stage biotechs. I am not a financial advisor. Opinions are my own.
Katılım Ekim 2021
239 Takip Edilen499 Takipçiler
$ASRT receives better BO offer from Zydus.
$23.50 per share vs the $21.80 offer from Garda
businesswire.com/news/home/2026…
English
$KALV Tender offer commenced. Expires 1 minute after 11:59pm ET on Jun 10, unless extended.
sec.gov/Archives/edgar…
English
The SEC today proposed rule and form amendments that would give public companies the option of filing semiannual reports in lieu of quarterly reports to meet their interim reporting obligations under the federal securities laws.
sec.gov/newsroom/press…
English
$VRDN
• REVEAL-2 met primary endpoint
• Elegrobart Q4W and Q8W achieved 50% and 54% proptosis responder rates (PRR) at week 24 vs 15% placebo (p < 0.0001)
• Elegrobart Q4W achieved 61% diplopia responder rate at week 24 vs 38% placebo (p = 0.0118)
businesswire.com/news/home/2026…
English
$CELC Did they really halt this for over an hour just to let everyone know that they are going to present the detailed data at ASCO 😂
TwongStocks@TwongStocks
$CELC Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort globenewswire.com/news-release/2…
English
$CELC Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
globenewswire.com/news-release/2…
English
$KALV Chiesi Group to Acquire KalVista Pharmaceuticals.
$27 per share, 1.9B equity valuation
chiesi.com/en/media-hub/p…
English
$SNGX Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte™ in Treatment of Cutaneous T-Cell Lymphoma
"Under the terms of the interim analysis, the study was recommended to halt for futility."
prnewswire.com/news-releases/…
English
$RCKT Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
businesswire.com/news/home/2026…
Cash runway extended into the second quarter of 2028
English
$SVRE PDUFA for Molgramostim extended three months to Nov 22, 2026.
investors.savarapharma.com/news/news-deta…
English
$LSTA The reason Kuva hasn't initiated the tender offer is that Kuva is looking for alternative sources to finance the tender. LSTA still "in discussions" with Kuva regarding the timing & commencement of the tender.
sec.gov/ix?doc=/Archiv…
English
$UA I think I have an idea for Under Armour.
Shay Boloor@StockSavvyShay
$BIRD is selling its brand and footwear assets renaming itself NewBird AI and using a new $50M convertible facility to pivot into AI compute infrastructure by buying GPUs. Going from selling wool sneakers to chasing AI compute might be one of the wildest pivots this cycle.
English
$LSTA The deadline for Kuva Labs to initiate their tender offer was extended from Apr 3 to Apr 13. It is now Apr 15 and there is complete radio silence.
@lisata_tx what is going on with Kuva's tender offer??
English
If I am reading this correctly, it looks like the SEC is approving NASDAQ's request to shift to a 23/5 trading system
23 hours of trading, 5 days a week.
public-inspection.federalregister.gov/2026-07259.pdf
To be published in tomorrow's Federal Register
English
FDA Issues Draft Guidance on Genome Editing Safety Standards to Advance Gene Therapy Development
Press release --> fda.gov/news-events/pr…
Draft guidance --> fda.gov/media/191966/d…
English
$TVTX Trading in Travere Therapeutics is scheduled to resume at 7:05am ET
nasdaqtrader.com/trader.aspx?id…
Halted yesterday prior to their announcement of FILSPARI approval in patients with FSGS who do not have nephrotic syndrome.
English
$TVTX Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS
businesswire.com/news/home/2026…
English